Edaravone early rehabilitation training combined term efficacy of the treatment of acute cerebral infarction.docVIP

 PAGE \* MERGEFORMAT 9 Edaravone early rehabilitation training combined term efficacy of the treatment of acute cerebral infarction [Abstract] Objective To observe the joint edaravone early rehabilitation training on acute cerebral infarction efficacy and safety. Methods 89 patients with acute cerebral infarction were randomly divided into two groups, 45 patients treated for early rehabilitation of the joint edaravone training in treatment and control group to Danshen injection therapy, were treated for 14 days. neurologic impairment before and after treatment (using the CSS scale score, Barthel Index scores were to determine clinical efficacy. Results after 14 days treatment, neurological defect score, Barthel Index score was significantly better than the control group (P lt;0.01. Conclusion edaravone treatment of early rehabilitation training combined with good effect in acute cerebral infarction, cerebral infarction significantly improved the neurological function. [Keywords:] edaravone, Salvia, cerebral infarction, rehabilitation training Acute cerebral infarction is a threat to health of the elderly common disease with high morbidity, a direct impact on patient prognosis and quality of life in recent years, its incidence is rising, the current effective therapy is thrombolytic and neuroprotective treatment. our department in recent years, the joint application of edaravone for acute cerebral infarction early rehabilitation to achieve better efficacy, are as follows. Materials and Methods 1. General Information Select diagnosed 89 cases of hospitalized patients with cerebral infarction, are consistent with the following inclusion criteria: meet the 1995 National Conference on the Fourth Amendment cerebrovascular disease diagnostic criteria [1], all patients by brain CT or MRI confirmed, hospital within 72 hours of onset, the first time, although the disease or previous history of stroke, showed no sequelae of this disease, into the group